Evidence map›Paper›PMID 33005269›Full record

ArticlePrzeglad gastroenterologiczny2020

The safety of upper gastrointestinal endoscopic biopsy in patients receiving antithrombic drugs. A single-centre prospective observational study.

Hilmi Bozkurt, Tolga Ölmez, Can İbrahim Bulut, Özlem Zeliha Sert, Zeynep Zehra Keklikkıran, Erdal Karaköse, Aziz Serkan Senger, Sabiye Akbulut, Erdal Polat, Mustafa Duman

Open access · goldAbstract read
In one paragraph

Article in Przeglad gastroenterologiczny, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. [IDEN Consensus on Management of Antithrombotic Agents in Patients Undergoing Gastrointestinal Endoscopy].The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi · 2024
    Review
  4. Review
  5. Article
  6. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Hilmi BozkurtGastrointestinal Surgery Department, Kartal Koşuyolu Training and Research Hospital, Istanbul, Turkey.
Tolga ÖlmezGastrointestinal Surgery Department, Kartal Koşuyolu Training and Research Hospital, Istanbul, Turkey.
Can İbrahim BulutGastrointestinal Surgery Department, Kartal Koşuyolu Training and Research Hospital, Istanbul, Turkey.
Özlem Zeliha SertGastrointestinal Surgery Department, Kartal Koşuyolu Training and Research Hospital, Istanbul, Turkey.
Zeynep Zehra KeklikkıranGastrointestinal Surgery Department, Kartal Koşuyolu Training and Research Hospital, Istanbul, Turkey.
Erdal KaraköseGastrointestinal Surgery Department, Kartal Koşuyolu Training and Research Hospital, Istanbul, Turkey.
Aziz Serkan SengerGastrointestinal Surgery Department, Kartal Koşuyolu Training and Research Hospital, Istanbul, Turkey.
Sabiye AkbulutGastroenterology Department, Kartal Koşuyolu Training and Research Hospital, Istanbul, Turkey.
Erdal PolatGastrointestinal Surgery Department, Kartal Koşuyolu Training and Research Hospital, Istanbul, Turkey.
Mustafa DumanGastrointestinal Surgery Department, Kartal Koşuyolu Training and Research Hospital, Istanbul, Turkey.
Kartal Koşuyolu High Specialization Training and Research Hospital · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionIn July 2012, the Japan Gastroenterological Endoscopy Society updated their guidelines on gastroenterological endoscopy in patients undergoing antithrombotic therapy, although the safety of endoscopic procedures in patients receiving antithrombotic drugs has yet to be sufficiently studied.

aimThis study evaluates the safety of upper gastroenterological endoscopic biopsy in patients receiving antithrombotic drugs. We evaluated the prospective observational safety of endoscopic biopsy performed in the endoscopy unit of our patients using antithrombotic drugs. MATERIAL AND

methodsOesophagogastroduodenoscopies (OGD) and biopsies performed at a single endoscopy unit between July 2018 and February 2019 were examined in this prospective observational study. Patients receiving antithrombotic drugs due to cardiovascular and neurological reasons, who underwent an endoscopic mucosal biopsy for diagnostic purposes, were included in the study.

resultsThe study was completed with 166 patients who underwent an endoscopic biopsy, from whom a total of 327 biopsies taken. The patients were examined in two groups: those "receiving antithrombotic drugs" and those who had "stopped taking antithrombotic drugs". There was no statistically significant difference between the two groups with respect to bleeding.

conclusionsThis prospective observational study showed that performing an endoscopic biopsy without the cessation of antithrombotic drugs does not increase bleeding risk. Low-risk procedures, such as endoscopic mucosal biopsies, can be performed confidently by experienced endoscopists.

Indexed as

antithromboticbleedingendoscopic biopsy

Identifiers

PMID33005269
PMCPMC7509902
OpenAlexW2979375239

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.